Clinical Study Results Sanofi Pharma, including Sanofi Genzyme

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country.
This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

Clinical study results Sanofi pharma, including Sanofi Genzyme – Letter T

GENERIC NAME	TRADE NAME	CONDITION	STUDY CODE	STUDY NAME	ACCESS TO STUDY / PROTOCOL	ACCESS TO RESULTS
TEICOPLANIN	Targocid	Clostridium Difficile Infection-associated Diarrhea and Colitis	LPS16229	NA	NCT04003818	Summary
TEICOPLANIN	Targocid	Infection	M000507_6004	TARGO-FEN	NCT00454272	Summary
TELITHROMYCIN	Ketek	Otitis Media, Acute	EFC6131 (HMR 3647A/3001)	NA	NCT00174811	Summary
TELITHROMYCIN	Ketek	Acute otitis media	EFC6132	TELI COM	NCT00315003	Summary
TELITHROMYCIN	Ketek	Tonsillitis, Pharyngitis	EFC6133	TELI TON	NCT00315042	Summary
TELITHROMYCIN	Ketek	Tonsillitis, Pharyngitis	EFC6134	TELI TAD	NCT00315549	Summary
TELITHROMYCIN	Ketek	Pneumonia, Community-Acquired	EFC6369 (HMR 3647B/3101)	NA	NCT00638859	Summary
TELITHROMYCIN	Ketek	Otitis Media, Acute	EFC6370 (HMR 3647B/3103)	NA	NCT00638534	Summary
TELITHROMYCIN	Ketek	Infection	EFC6371 (HMR 3647B/3104)	NA	NCT00408135	Summary
TELITHROMYCIN	Ketek	Asthma	HMR3647A_3503	TELICAST	NCT00273520	Summary
TELITHROMYCIN	Ketek	Infection	HMR3647A_4014	STROBE	NCT00538148	Summary
TELITHROMYCIN	Ketek	Infection	HMR3647A_4015	COBRA	NCT00538018	Summary
TELITHROMYCIN	Ketek	Infection	HMR3647A_4017	NA	NCT00537563	Summary
TELITHROMYCIN	Ketek	Infection	HMR3647A_4018	NA	NCT00546676	Summary
TELITHROMYCIN	Ketek	Infection	HMR3647A_4019	KEYS	NCT00132951	Summary
TELITHROMYCIN	Ketek	Infection	HMR3647A_4020	PERSPECTIVE	EudraCT: 2004-001412-30	Summary Results
TELITHROMYCIN	Ketek	Infection	HMR3647A_4022	SCOPE	NCT00288223	Summary
TELITHROMYCIN	Ketek	Sinusitis, Acute Bacterial	HMR3647A_4023	CHOOSE	NCT00174694	Summary
TELITHROMYCIN	Ketek	Infection	HMR3647A_4026	NA	NCT00261105	Summary
TELITHROMYCIN	Ketek	Infection	HMR3647A_4027	COBRA II	NCT00237445	Summary
Teriflunomide	Aubagio	Multiple Sclerosis	BDR16019	TERI-PK	NCT04410965	Summary
TERIFLUNOMIDE	Aubagio	Multiple Sclerosis	HMR11726D/2001	NA	NCT01487096	Publication's reference
TERIFLUNOMIDE	Aubagio	Multiple Sclerosis	EFC6049	TEMSO	NCT00134563	Tabulated Results
TERIFLUNOMIDE	Aubagio	Multiple Sclerosis	PDY6046	NA	NCT00475865	Tabulated Results
TERIFLUNOMIDE	Aubagio	Multiple Sclerosis	PDY6045	NA	NCT00489489	Tabulated Results
TERIFLUNOMIDE	Aubagio	Multiple Sclerosis	LTS6047	NA	NCT00811395	Tabulated Results
TERIFLUNOMIDE	Aubagio	Multiple Sclerosis	EFC10891	TENERE	NCT00883337	Tabulated Results
TERIFLUNOMIDE	Aubagio	Multiple Sclerosis	PDY11684	TERIVA	NCT01403376	Tabulated Results
TERIFLUNOMIDE	Aubagio	Multiple Sclerosis	POP11432	NA	NCT01239459	Summary
TERIFLUNOMIDE	Aubagio	Multiple Sclerosis	EFC10531	TOWER	NCT00751881	Tabulated Results
TERIFLUNOMIDE	Aubagio	Multiple Sclerosis	EFC6058	TERACLES	NCT01252355	Tabulated Results
TERIFLUNOMIDE	Aubagio	Multiple Sclerosis	EFC6260	TOPIC	NCT00622700	Tabulated Results
	Aubagio	Multiple Sclerosis	LPS13539	TERIDYNAMIC	EudraCT: 2012-005324-16	Tabulated Results Posted
TERIFLUNOMIDE	Aubagio	Multiple Sclerosis	PKM12788	NA	NCT02046629	Summary
TERIFLUNOMIDE	Aubagio	Multiple Sclerosis	LTS6048	NA	NCT00228163	Publication's reference
TERIFLUNOMIDE	Aubagio	Multiple Sclerosis	LPS13567	TERI-PRO	NCT01895335	Tabulated Results
TERIFLUNOMIDE	Aubagio	Multiple Sclerosis	LTS6050	NA	EudraCT: 2006-003361-14	Tabulated Results
TESEVATINIB	Not Marketed	Non-Small Cell Lung Cancer Leptomeningeal Metastases Brain Metastases	KD019-206	NA	NCT02616393	Tabulated Results
TESEVATINIB	Not Marketed	Glioblastoma Recurrent Glioblastoma Brain Tumor	KD019-208	NA	NCT02844439	Tabulated Results
TESEVATINIB	Not Marketed	HER-2 Positive Breast Cancer Metastatic Malignant Neoplasm to Brain	KD019-204	NA	NCT02154529	Tabulated Results
TESEVATINIB	Not Marketed	Solid Tumors	XL647-001	NA	NCT00086528	Publication reference
TESEVATINIB	Not Marketed	Solid Tumors	XL647-002	NA	NCT00336765	Publication reference
TESEVATINIB	Not Marketed	Non-small-cell Lung Cancer	XL647-201	NA	NCT00364780	Publication reference
TESEVATINIB	Not Marketed	Carcinoma Non-Small-Cell Lung	XL647-203	NA	NCT00522145	Publication reference
TESEVATINIB	Not Marketed	Polycystic kidney, autosomal dominant	KD019-101	NA	NCT01559363	Tabulated results
THIOCOLCHICOSIDE	Muscoril, Myoril	Pain	L_9826	MYLOBAC	NCT00917436	Summary
THIOCOLCHICOSIDE	Muscoril, Myoril	Pain	L_9892	EMINEM	NCT00272532	Summary
THIOCOLCHICOSIDE+ KETOPROFEN	Muscoril Plus	Pain	KETOP_R_02693	TIOKET	NCT00679146	Summary
THYROTROPIN ALFA	Thyrogen	Diagnostic Tool for Thyroglobulin Testing	THYR00700*			Summary
THYROTROPIN ALFA	Thyrogen	Diagnostic Tool for Thyroglobulin Testing	THYR00800*		NCT00196729	Summary
THYROTROPIN ALFA	Thyrogen	Diagnostic Tool for Thyroglobulin Testing	THYR01605	NA	EUdraaCT: 2005-004450-27	Summary Results
THYROTROPIN ALFA	Thyrogen	Diagnostic for Detection of Thyroid Cancer	TSH92-0601*			Summary
THYROTROPIN ALFA	Thyrogen	Thyroid Cancer	TSH94-0301*			Summary
THYROTROPIN ALFA	Thyrogen	Diagnostic for Detection of Thyroid Cancer	TSH95-0101*			Summary
TLR4 AGONIST IMMUNOMODULATOR	Not Marketed	Food Allergy	TDR14287	NA	NCT03463135	Summary
TOFOGLIFLOZIN	TOFOGLIFLOZIN	Diabetes Mellitus Type 2	TOFOGL07061	NA	NCT02201004	Summary
TRIAMCINOLONE ACETONIDE	Nasacort AQ	Rhinitis	TRICA_L_00872	RhiCNANI	NCT00344942	Summary
TRIAMCINOLONE ACETONIDE	Nasacort	Rhinitis Allergic	TRICAL07830	NASANIF	NCT03317015	Summary
TRIAMCINOLONE ACETONIDE	Nasacort AQ	Rhinitis Allergic	TRICA_L_04286	NA	NCT01154153	Tabulated Results
TRIAMCINOLONE ACETONIDE	Nasacort AQ	Allergic Rhinitis	XRG5029C_1000	NA	NA	Summary
TRIAMCINOLONE ACETONIDE	Nasacort AQ	Allergic Rhinitis	XRG5029C_3502	NA	NCT00132925	Summary
TRIAMCINOLONE ACETONIDE	Nasacort AQ	Rhinitis Allergic	XRG5029C_3503	PAR	NCT00449072	Tabulated Results
TRIAMCINOLONE ACETONIDE	Nasacort AQ	Allergic Rhinitis	XRG5029C_4002	NA	NA	Summary
TRIAMCINOLONE ACETONIDE	Nasacort AQ	Allergic Rhinitis	XRG5029C_4004	SMART	NA	Summary
TRIAMCINOLONE ACETONIDE	Nasacort AQ	Allergic Rhinitis	XRG5029C_4005	NA	NA	Summary
TRIAMCINOLONE ACETONIDE	Nasacort AQ	Allergic Rhinitis	XRG5029C_4006	NA	NA	Summary
TRIAMCINOLONE ACETONIDE	Nasacort AQ	Allergic Rhinitis	XRG5029C_4007	NA	NA	Summary
TRKA INHIBITOR	Not marketed	Osteoarthritis	TDU13828 / ACT13830	NA	EudraCT: 2014-004805-34	Summary
TRPV3 ANTAGONIST	Not marketed	Neuropathic pain	ACT11917	ALCHEMILLA	summary on EudraCT: 2011-001876-21	Summary Results Posted

References:
*These study results were previously posted on GenzymeClinicalResearch.com
**This link replaces the same summary that was previously posted